Functional characterization ofNTRK1mutations identified in melanoma

Kinase fusions are frequent in Spitz tumours and spitzoid melanomas

(2014) Thomas Wiesner et al.   Nature Communications

The Genetics of Melanoma: Recent Advances

(2013) Victoria K. Hill et al.   Annual Review of Genomics and Human Genetics

Update on the Targeted Therapy of Melanoma

(2013) Douglas B. Johnson et al.   CURRENT TREATMENT OPTIONS IN ONCOLOGY

Oncogenic and drug-sensitive NTRK1 rearrangements in lung cancer

(2013) Aria Vaishnavi et al.   NATURE MEDICINE

KRAS and BRAF Mutations Predict Primary Resistance to Imatinib in Gastrointestinal Stromal Tumors

(2012) C. Miranda et al.   CLINICAL CANCER RESEARCH

New Strategies in Metastatic Melanoma: Oncogene-Defined Taxonomy Leads to Therapeutic Advances

(2011) K. T. Flaherty et al.   CLINICAL CANCER RESEARCH

Role and Relevance of TrkB Mutations and Expression in Non-Small Cell Lung Cancer

(2011) T. Harada et al.   CLINICAL CANCER RESEARCH

The melanomas: a synthesis of epidemiological, clinical, histopathological, genetic, and biological aspects, supporting distinct subtypes, causal pathways, and cells of origin

(2011) David C. Whiteman et al.   Pigment Cell & Melanoma Research

Functional Characterization of Human Cancer-Derived TRKB Mutations

(2011) Thomas R. Geiger et al.   PLoS One

IGFBP7: an oncosuppressor gene in thyroid carcinogenesis

(2010) M G Vizioli et al.   ONCOGENE

Rearrangements of NTRK1 gene in papillary thyroid carcinoma

(2009) A. Greco et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY

Analysis of the tyrosine kinome in melanoma reveals recurrent mutations in ERBB4

(2009) Todd D Prickett et al.   NATURE GENETICS

Neurotrophins and Their Receptors Stimulate Melanoma Cell Proliferation and Migration

(2008) Francesca Truzzi et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY